SelectScience InterviewsLife Sciences

Novel GPCR Internalization Assays Enable Drug Discovery

11 Apr 2011
Novel GPCR Internalization Assays Enable Drug Discovery

In this interview at SBS 2011, DiscoveRx discuss the new PathHunter® GPCR eXpress Internalization Assay. These chemiluminescent assays can be used to measure functionalisation and endocytosis of GPCRs. In addition, DiscoveRx announce the merger with KINOMEscan™, to provide a profiling service for measuring the interaction of compounds against kinsases to discover putative drug candidates.

Other videos from DiscoveRx Corporation

Links